Report comparison
Compare up to four published reports side by side.
| Field | Global Drug Eluting Balloons Market Analysis and Forecasts 2021-2031 |
|---|---|
| Publisher | Market Research IQ |
| Price | $2,499 |
| Pages | 152 |
| Base year | 2021 |
| Forecast | 2026-2031 |
| Regions | Geographically, the drug eluting balloons market demonstrates varying growth patterns. North America leads in market size due to advanced healthcare infrastructure. Europe follows closely, with steady growth rates attributed to technological advancements. The Asia-Pacific region is projected to witness the highest growth, fueled by rising population and changing lifestyles. Regional market value outlook Region Base year value (USD Billion) Forecast year value (USD Billion) North America 410 660 Europe 270 430 Asia-Pacific 200 410 Latin America 60 90 Middle East & Africa 45 40 |
| Segments | The drug eluting balloons market can be segmented based on type, application, end-user, and distribution channel. The leading segments include: Type: Conventional DEBs Application: Cardiovascular Procedures End User: Hospitals Distribution: Direct Sales Segment market mix Group Lead segment Share (%) Growth signal Insight By Type Conventional DEBs 40 High Dominates due to established efficacy. By Application Hospitals 50 High Steady demand driven by surgical interventions. By End User Hospitals 23 active buyer group Hospitals drive demand through recurring procurement, modernization, and performance improvement needs. By Distribution Direct Sales 55 High Preferred method for institutional sales. |
| Rating | New |
| Reviews | 0 |